CVRx names John Landry as CFO

CVRx names John Landry as CFO is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-09-23

Landry joins in the aftermath of an investor’s call for the sale of the heart failure device company.

Source: MedTech Dive